340B program

A new report says hospitals, clinics and for-profit partners received $142 billion in 2025 through the 340B drug discount program, a federal scheme meant to help safety-net providers serve low-income patients. The figure is likely to fuel debate over whether the program's benefits are reaching patients or being captured by large hospital systems and commercial intermediaries.